These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26346170)

  • 1. 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules.
    Lai KK; Chan KT; Choi MY; Wang HK; Fung EY; Lam HY; Tan W; Tung LN; Tong DK; Sun RW; Lee NP; Law S
    Tumour Biol; 2016 Feb; 37(2):2127-36. PubMed ID: 26346170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts.
    Lee NP; Chan KT; Choi MY; Lam HY; Tung LN; Tzang FC; Han H; Lam IP; Kwok SY; Lau SH; Man C; Tong DK; Wong BL; Law S
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1199-207. PubMed ID: 26553104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
    Li DJ; Shi M; Wang Z
    Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ.
    Qin X; Qiu F; Zou Z
    Biochem Biophys Res Commun; 2017 Nov; 493(1):568-572. PubMed ID: 28867193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
    Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
    Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
    Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
    BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
    Chen C; Ma Z; Zhang H; Liu X; Yu Z
    Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of SGTA in esophageal squamous cell carcinoma correlates with proliferation and poor prognosis.
    Yang X; Cheng L; Li M; Shi H; Ren H; Ding Z; Liu F; Wang Y; Cheng C
    J Cell Biochem; 2014 Jan; 115(1):141-50. PubMed ID: 23939810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage.
    Hui MK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S
    World J Surg; 2012 Jan; 36(1):90-7. PubMed ID: 21976009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of 14-3-3σ correlates with multistage carcinogenesis and poor prognosis of esophageal squamous cell carcinoma.
    Qi YJ; Wang M; Liu RM; Wei H; Chao WX; Zhang T; Lou Q; Li XM; Ma J; Zhu H; Yang ZH; Liu HQ; Ma YF
    PLoS One; 2014; 9(4):e95386. PubMed ID: 24743601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma.
    Liu X; Ma W; Yan Y; Wu S
    J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28914995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomic analysis of the esophageal squamous carcinoma cell line EC109 and its multi-drug resistant subline EC109/CDDP.
    Wen J; Zheng B; Hu Y; Zhang X; Yang H; Li Y; Zhang CY; Luo KJ; Zang X; Li YF; Guan XY; Fu JH
    Int J Oncol; 2010 Jan; 36(1):265-74. PubMed ID: 19956855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma.
    Hui MK; Lai KK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S
    Med Oncol; 2012 Dec; 29(5):3009-16. PubMed ID: 22528514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes.
    Kuo IY; Huang YL; Lin CY; Lin CH; Chang WL; Lai WW; Wang YC
    J Biomed Sci; 2019 Feb; 26(1):20. PubMed ID: 30777052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
    Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
    Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors.
    Rafiq R; Bhat GA; Lone MM; Masood A; Dar NA
    Tumour Biol; 2016 Aug; 37(8):10193-207. PubMed ID: 26831662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1.
    Ge R; Liu L; Dai W; Zhang W; Yang Y; Wang H; Shi Q; Guo S; Yi X; Wang G; Gao T; Luan Q; Li C
    J Invest Dermatol; 2016 Jun; 136(6):1219-1228. PubMed ID: 26880244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of cyclinH and cyclin-dependent kinase 7 can decrease the proliferation of human esophageal squamous cell carcinoma.
    Zhang J; Yang X; Wang Y; Shi H; Guan C; Yao L; Huang X; Ding Z; Huang Y; Wang H; Cheng C
    Dig Dis Sci; 2013 Jul; 58(7):2028-37. PubMed ID: 23456497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hOGG1 over-expression on cisplatin resistance in esophageal squamous carcinoma cells.
    Gao D; Hu J; Zhang X; Gao C; Hong J
    Cancer Biother Radiopharm; 2013; 28(6):433-40. PubMed ID: 23806019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.
    Chen Y; Li Z; Dong Z; Beebe J; Yang K; Fu L; Zhang JT
    Mol Cancer Res; 2017 Apr; 15(4):418-428. PubMed ID: 28087741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.